Jingjing Feng

5PUBLICATIONS
12CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 08, 2026
Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR-T Treated T-cell Lymphoid Malignancies.

|Jan 13, 2023
Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation.

Xiangjun Zeng, Xiaoqing Li, Xia Li

|Jan 29, 2022
Profile of capillary-leak syndrome in patients received chimeric antigen receptor T cell therapy.

Jingjing Feng, Mi Shao, Yongxian Hu

|Feb 02, 2020
CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations.

Aiyun Jin, Jingjing Feng, Guoqing Wei

|Dec 20, 2018
Severe dyspnea caused by rapid enlargement of cervical lymph node in a relapsed/refractory B-cell lymphoma patient following chimeric antigen receptor T-cell therapy.

Aiyun Jin, Jingjing Feng, Zhudan Wang

Pageof 1

Frequent Collaborators

4 joint publications

He Huang

2 joint publications

Yongxian Hu

1 joint publications

Meng Zhang

1 joint publications

Pengxu Qian